{rfName}
Th

Indexed in

License and use

Citations

1

Altmetrics

Analysis of institutional authors

Walbaum, BenjaminAuthorSegui, EliaAuthorMunoz, MontserratAuthor

Share

March 21, 2025
Publications
>
Review
No

The role of artificial intelligence integrating multi-omics in breast cancer

Publicated to:Revista De Senologia Y Patologia Mamaria. 38 (3): 100677- - 2025-07-01 38(3), DOI: 10.1016/j.senol.2025.100677

Authors: Gomez-Bravo, Raquel; Walbaum, Benjamin; Segui, Elia; Munoz, Montserrat

Affiliations

August Pi & Sunyer Biomed Res Inst IDIBAPS, Translat Genom & Targeted Therapies Solid Tumors, Barcelona, Spain - Author
Dana Farber Canc Inst, Breast Oncol Ctr, Boston, MA USA - Author
Hosp Clin Barcelona, Canc Inst & Blood Dis, Barcelona, Spain - Author
Pontificia Univ Catolica, Dept Med Oncol, Santiago, Chile - Author
Pontificia Univ Catolica, Fac Med, Santiago, Chile - Author
SOLTI Breast Canc Res Grp, Barcelona, Spain - Author
See more

Abstract

In an era of precision oncology, genomic testing plays a crucial role in the management of breast cancer. A variety of complex techniques for germline, somatic, and gene expression testing are routinely used as part of our clinical practice. However, challenges remain in both interpreting genomic data and in the ever-expanding breadth of available tumor information. Artificial intelligence (AI), specifically machine learning and deep learning models, can create and facilitate the interpretation of complex genetic data, predict patient outcomes, and personalize treatment plans. Herein, we present a review of the current role of AI integrating multi-omics in BC.

Keywords

Artificial intelligenceBreast cancerGene expressioMachine learningMulti-omicsScorTherapyTrial

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Revista De Senologia Y Patologia Mamaria, and although the journal is classified in the quartile Q4 (Agencia WoS (JCR)), its regional focus and specialization in Oncology, give it significant recognition in a specific niche of scientific knowledge at an international level.

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-09-13:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 5.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 7 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 3.7.
  • The number of mentions on the social network X (formerly Twitter): 6 (Altmetric).

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: Chile; United States of America.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Gomez-Bravo, Raquel) and Last Author (Muñoz Mateu, Montserrat).

the author responsible for correspondence tasks has been Gomez-Bravo, Raquel.